Park Medi World financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹476cr 
Net profit
₹88.6cr 
EBITDA margin
26.5% 
EPS
₹2.05 

Quarterly results

Every quarter ›
₹ croreQ1 FY27Year beforeChange
Revenue476——
EBITDA126——
EBITDA margin26.5%——
Profit before tax105——
Net profit88.6——
EPS₹2.05——

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹476 crNet profit₹88.6 crNet margin18.6%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast closeFY26Mar 2026
9,803—
237237
82.382.3
228228
9,876—
1,6791,679
444444
26.5%26.5%
382382
274274
16.3%16.3%
₹5.98₹5.98
329329
−120−120
209209
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

PARKHOSPS₹226.95

Park Medi World Ltd.

· Pharma & Health
₹ CrorePeersMAXHEALTHFORTISMEDANTAMETROPOLISMARKSANSRUBICONJLHLSHILPAMEDMcap ₹9,803 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Current
last close
Market Capitalization—9,802.7
- Cash, Equiv & ST Investments236.9236.9
+ Minority Interest82.382.3
+ Total Debt227.9227.9
Enterprise Value—9,876.0
Revenue1,679.41,679.4
EBITDA444.3444.3
Margin %26.4626.46
EBIT381.9381.9
Net Income273.6273.6
Margin %16.2916.29
EPS, Adj (current shares)5.985.98
Cash from Operations329.1329.1
Capital Expenditures-119.7-119.7
Free Cash Flow209.4209.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Park Medi World financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Park Medi World (NSE: PARKHOSPS) had a market capitalisation of ₹9,556 crore at the 29 October 2026 close (₹221.25 a share) and a price-to-book ratio of 4.73. In FY26 its consolidated net profit attributable to shareholders was ₹258 crore on revenue of ₹1,679 crore; in Q1 FY27 (April–June 2026) it was ₹82.5 crore. Its debt-to-equity ratio was 0.11 on 31 March 2026. Promoters held 82.90% of the shares on 30 September 2026.

Share price used
₹221.25 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Park Medi World at a glance · consolidated

Market cap
₹9,556 Crat ₹221.25 · 29 Oct close
PE ratio
n/a
Price to book (PB)
4.73book value ₹46.81 a share
Debt to equity
0.11net cash ₹203 Cr
Promoter holding
82.90%unchanged vs 30 Jun 202630 September 2026
Net worth
₹2,022 Cr31 March 2026

Questions

What is the Park Medi World PB ratio (price to book value)?

Park Medi World's price-to-book (PB) ratio is 4.73 at the 29 October 2026 close: a market capitalisation of ₹9,556 crore divided by shareholders' equity (book value) of ₹2,022 crore on 31 March 2026. That is a book value of ₹46.81 per share against a share price of ₹221.25.

What is the Park Medi World net worth?

Park Medi World's net worth — shareholders' equity in its consolidated balance sheet — was ₹2,022 crore on 31 March 2026. Its market value is a different figure: a market capitalisation of ₹9,556 crore at the 29 October 2026 close.

What is the Park Medi World shareholding pattern?

On 30 September 2026, Park Medi World's shares were held by promoters 82.90%, foreign portfolio investors (FII/FPI) 0.88%, domestic institutions (DII) 8.24% (including mutual funds at 5.39%) and retail and other non-institutional investors 7.99%.

What is the Park Medi World market cap?

Park Medi World's market capitalisation was ₹9,556 crore at the 29 October 2026 close: 43.19 crore shares at ₹221.25 each.

Is Park Medi World debt free?

No. Park Medi World had borrowings of ₹228 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.11. Its cash and current investments were ₹431 crore, so it held net cash of ₹203 crore.

What is the Park Medi World debt to equity ratio?

Park Medi World's debt-to-equity ratio was 0.11 on 31 March 2026: borrowings of ₹228 crore against total equity of ₹2,104 crore.

What is the Park Medi World book value per share?

Park Medi World's book value per share was ₹46.81 on 31 March 2026: shareholders' equity of ₹2,022 crore divided by the 43.19 crore shares in issue. The share price at the 29 October 2026 close was ₹221.25.

What is the Park Medi World promoter holding?

Promoters held 82.90% of Park Medi World on 30 September 2026, up 0.01 percentage points from 82.89% the previous quarter, according to the shareholding pattern filed with NSE.

What are the Park Medi World latest quarterly results?

Park Medi World's latest results are for Q1 FY27 (April–June 2026), filed on 3 August 2026: consolidated net profit attributable to shareholders ₹82.5 crore; revenue from operations ₹476 crore.

What is the Park Medi World EPS?

Park Medi World's basic earnings per share (EPS) were ₹6.87 in FY26.

What is the Park Medi World free cash flow?

In FY26, Park Medi World generated ₹329 crore of cash from operations and spent ₹120 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹209 crore.

What is the Park Medi World revenue and profit in FY26?

In FY26 (April 2025–March 2026), Park Medi World's consolidated net profit attributable to shareholders was ₹258 crore, on revenue from operations of ₹1,679 crore.

When are the Park Medi World next results?

Park Medi World has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.

How does Park Medi World compare with its peers?

On FY26 consolidated figures, against Max Healthcare Institute, Fortis Healthcare and Global Health: Park Medi World's operating margin of 22.7% is the highest of the four (Max Healthcare Institute 21.5%, Fortis Healthcare 17.9%, Global Health 15.8%; peer average 18.4%).

How does the Park Medi World PE ratio compare with its peers?

At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, Park Medi World's PE ratio is 37.0, the lowest of the four: Max Healthcare Institute 57.4, Fortis Healthcare 54.7 and Global Health 62.8, a peer average of 58.3. Each is the company's market capitalisation at that price divided by its FY26 net profit.

Park Medi World vs Max Healthcare Institute: how do they compare?

In FY26, Park Medi World earned net profit attributable to shareholders of ₹258 crore on revenue of ₹1,679 crore, against ₹1,442 crore on ₹8,373 crore for Max Healthcare Institute. Park Medi World's operating margin was 22.7% (Max Healthcare Institute 21.5%). At the 29 October 2026 close, Park Medi World's market capitalisation was ₹9,556 crore against ₹82,837 crore for Max Healthcare Institute, and its PE ratio on FY26 profit 37.0 against 57.4.

Where do these Park Medi World figures come from?

From Park Medi World's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.